Manuscript Guidelines

The title should not be more than 15 words long. The title should be a proper description of the work provided. The font must be Times New Roman Bold and title case.

The abstract should describe the study's main goals. It should be able to summarise all of the work. The study's significance and findings must be summarised briefly. The word limit for the abstract should be 300 words. Please keep in mind that abstracts should not contain any citations.

It is necessary to mention the study's main keywords. The maximum number of keywords allowed is seven to ten.

If any abbreviations are used in the study, the full name of the abbreviation must be given first, followed by the abbreviation in brackets. If the number of abbreviations is excessive, they must be listed after the keywords.

The introduction should be able to provide context for the study. It should also include a detailed description of the study's objective and significance. The introduction should be detailed and include citations.

Specific facts and/or practices must be specified for novel approaches. It is necessary to include the relevant citations for the protocols that were employed. The outcomes must be unique and must not be plagiarized from other sources. Researchers should be able to fully reproduce your study using the information in this area. For less well-established approaches, we recommend that authors give full protocols.

Subsections could be created inside this section. The results and discussions must deliver the outcomes. Make a diagram of the experiment results, their interpretations, and conclusions.

Authors should explain how the findings relate to the study's foundational idea and give a brief explanation of the findings' allegation.

The authors must give financing information as well as any grant numbers. They may acknowledge the work that has been supported by them.

Authors should include at least one online link in their references, as shown below (preferably PubMed. For the reference list, please use the following format.

3.10.1 Journal References

1. • Type 1: Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatinfor gastric cancer after D2 gastrectomy (CLASSIC): a phase3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–321.
2. • Type 2: Leung WK. Screening for gastric cancerin Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–287.
3. • Type 3: Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. PLoS One. 1999;9(3):e90479.
4. • Volume with supplement: Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93–99.
5. • Issue with supplement: Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6–12.
6. • Volume with part: Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002;83(Pt 2):491–495.
7. • Issue with part: Ahrar K, Madoff DC, Gupta S, et al. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923–928.
8. • Issue with no volume: Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230–238.

3.10.2 Book References

1. • Personal author(s): Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4^th ed. St. Louis: Mosby; 2002.
2. • Editor(s), compiler(s) as author: Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2^nd ed. New York: McGraw-Hill; 2002.
3. • Author(s) and editor(s):

   (i) Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2^nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

   (ii) Sánchez A, Fernández-Real J, Vegas E, et al. Multivariate methods for the integration and visualization of omics data. In: Freitas AT, Navarro A, editors. Bioinformatics for Personalized Medicine. Lecture Notes in Computer Science. Berlin, Heidelberg: Springer; 2012: 6620.

   (iii) Zhang L, Lin X. Multivariate statistical methods in bioinformatics research. In: Jiang R, Zhang X, Zhang M, editors. Basics of Bioinformatics. Berlin, Heidelberg: Springer; 2013:63–231.

4. • Organization(s) as author:

   (i) Advanced Life Support Group. Acute medical emergencies: the practical approach. London: BMJ Books; 2001. 454 p.

   (ii) American Occupational Therapy Association, Ad Hoc Committee on Occupational Therapy Manpower. Occupational therapy manpower: a plan for progress. Rockville (MD): The Association; 1985 Apr. 84 p.

   (iii) National Lawyer's Guild AIDs Network (US); National Gay Rights Advocates (US). AIDS practice manual: a legal and educational guide. 2^nd ed. San Francisco: The Network; 1988.

5. • Chapter in a book: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
6. • Conference proceedings: Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.
7. • Conference paper: Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5^th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.